BRIEF published on 01/07/2026 at 22:10, 3 months 29 days ago Abivax dévoile ses plans stratégiques pour 2026 Dépôt Réglementaire Perspectives D'Abivax Pour 2026 Marché De La Colite Ulcéreuse Essais Cliniques Sur L'obefazimod Recherche Sur La Maladie De Crohn
PRESS RELEASE published on 01/07/2026 at 22:05, 3 months 29 days ago Abivax présente ses perspectives pour 2026 Abivax présente ses perspectives pour 2026, annonçant des nouveautés dans le traitement de la rectocolite hémorragique, les progrès des essais ABTECT-UC et ENHANCE-CD, et l'avancement de son portefeuille de candidats médicaments Abivax Maladies Inflammatoires Chroniques Rectocolite Hémorragique Essais Cliniques Perspectives 2026
PRESS RELEASE published on 01/07/2026 at 22:05, 3 months 29 days ago Abivax Provides 2026 Corporate Outlook Abivax provides 2026 corporate outlook, highlighting market insights, trial progress, and pipeline advancements in treating chronic inflammatory diseases like UC and CD Abivax Chronic Inflammatory Diseases 2026 Corporate Outlook UC CD
BRIEF published on 12/18/2025 at 22:10, 4 months 18 days ago Abivax rejoint l'indice Nasdaq Biotechnology Biotechnologie Abivax Obefazimod Rectocolite Hémorragique Nasdaq Biotechnology
BRIEF published on 12/18/2025 at 22:10, 4 months 18 days ago Abivax joins the Nasdaq Biotechnology index Biotechnology Abivax Obefazimod Ulcerative Colitis Nasdaq Biotechnology
BRIEF published on 12/18/2025 at 22:10, 4 months 18 days ago Abivax Joins Nasdaq Biotechnology Index Biotechnology Abivax Obefazimod Ulcerative Colitis Nasdaq Biotechnology Index
BRIEF published on 12/18/2025 at 22:10, 4 months 18 days ago Abivax intègre l'indice Nasdaq Biotechnology Biotechnologie Abivax Obefazimod Rectocolite Hémorragique Indice Nasdaq Biotechnology
PRESS RELEASE published on 12/18/2025 at 22:05, 4 months 18 days ago Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology Abivax intègre l'Indice Biotechnologie du Nasdaq, témoignant de sa croissance et de ses avancées cliniques. Le NBI suit les performances des sociétés du secteur Biotechnologie Abivax Nasdaq Clinique NBI
PRESS RELEASE published on 12/18/2025 at 22:05, 4 months 18 days ago Abivax fait son entrée au sein de l'indice Nasdaq Biotechnology Abivax intègre l'indice Nasdaq Biotechnology, rejoignant le NBI avec impact le 22 décembre 2025. Un pas significatif pour la société de biotechnologie française Biotechnologie Abivax France Nasdaq Biotechnology Indice
PRESS RELEASE published on 12/18/2025 at 22:05, 4 months 18 days ago Abivax to be Added to Nasdaq Biotechnology Index Abivax to be added to Nasdaq Biotechnology Index, reflecting company's progress in developing therapeutics for chronic inflammatory diseases. Inclusion effective December 22, 2025 Biotechnology Abivax Therapeutics Immune Response Nasdaq Biotechnology Index
Published on 05/06/2026 at 09:01, 2 hours ago Apex Widens and Extends Newly Discovered Zone with Significant NdPr Enrichment (>30%)
Published on 05/06/2026 at 02:17, 8 hours 44 minutes ago Troubadour Announces Share Consolidation and Effective Date
Published on 05/06/2026 at 02:00, 9 hours 1 minute ago Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
Published on 05/06/2026 at 02:00, 9 hours 1 minute ago Alset AI Announces Shares for Debt Transaction
Published on 05/06/2026 at 10:45, 16 minutes ago Thailand Approves $29 Billion Investment Wave as Data Center Demand Surges
Published on 05/06/2026 at 10:00, 1 hour 1 minute ago 2026 Pacific Ocean International Festival of Rock Balancing and Arts Holds Grand Opening at Qixingtan Scenic Area on May 1st
Published on 05/06/2026 at 10:00, 1 hour 1 minute ago Mallia Therapeutics Announces Publication and Congress Presentation on Accelerated Wound Healing with sCD83
Published on 05/06/2026 at 10:00, 1 hour 1 minute ago MAKTEK Eurasia 2026 positions Türkiye as a manufacturing hub
Published on 05/06/2026 at 10:09, 52 minutes ago Guillemot Corporation : Information regarding the total number of voting rights and shares 30/04/2026
Published on 05/06/2026 at 10:09, 52 minutes ago Guillemot Corporation : Informations relatives au nombre total de droits de vote et d’actions 30/04/2026
Published on 05/06/2026 at 09:09, 1 hour 52 minutes ago Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Published on 05/06/2026 at 08:42, 2 hours 19 minutes ago Disclosure of shares outstanding and voting rights - 06.05.2026
Published on 05/06/2026 at 08:42, 2 hours 19 minutes ago Déclaration nombre d'actions et droits de vote - 06.05.2026
